Ana Oliveira Hoff
Universidade de São Paulo
H-index: 38
Latin America-Brazil
Top articles of Ana Oliveira Hoff
Differentiated thyroid carcinoma: what the nonspecialists needs to know
2024
Not Only RET but NF1 and Chromosomal Instability Are Seen in Young Patients with Sporadic Medullary Thyroid Carcinoma
Journal of the Endocrine Society
2024/6
Intraoperative radiofrequency ablation for unresectable abdominal paraganglioma: a case report
Frontiers in Endocrinology
2024/4/15
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
2024/2
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular …
Thyroid
2024/1/23
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
New England Journal of Medicine
2023/11/16
604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC …
Annals of Oncology
2023/11/1
LBA3 Randomized phase III study of selpercatinib versus cabozantinib or vandetanib in advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer
Annals of Oncology
2023/10/1
SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
Journal of the Endocrine Society
2023/10
Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)
Clinics
2023/8/21
Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma
The Journal of Clinical Endocrinology & Metabolism
2023/8
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review
2023/6/8
Ultrasound in cervical traumatic neuromas after neck dissection in thyroid carcinoma patients: descriptive analysis and diagnostic accuracy
Archives of endocrinology and metabolism
2023/6/5
Debora Lucia Seguro Danilovic
H-Index: 8
Ana Oliveira Hoff
H-Index: 21
Ricardo Miguel Costa De Freitas
H-Index: 8
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial
Cancer
2022/12/15
Cytoreductive surgery of the primary tumor in metastatic adrenocortical carcinoma: impact on patients’ survival
The Journal of Clinical Endocrinology & Metabolism
2022/4/1
Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases
Endocrine
2022/3/1
Beatriz Godoi Cavalheiro
H-Index: 6
Ana Oliveira Hoff
H-Index: 21
Effect of Age on the Efficacy and Safety of Cabozantinib compared to Placebo in Patients with radioiodine-refractory (RAIR) differentiated Thyroid Cancer (DTC) who progressed …
2022
RF09| PSUN29 Evidence for a Founder Effect of SDHB Exon 1 Complete Deletion in Brazilian Patients with Paraganglioma
Journal of the Endocrine Society
2022/11/1
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)
Archives of Endocrinology and Metabolism
2022/9/30
1653P Cabozantinib (C) vs placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who progressed after prior VEGFR-targeted therapy …
Annals of Oncology
2022/9/1
Co-Authors
